Company: Evox Therpaeutics
Job title: Co-Founder & Chief Operating Officer
Dr Per Lundin has over 10 years of experience founding, leading and advising biotech companies developing groundbreaking therapies. Dr Lundin is co-founder of Evox Therapeutics and has acted as the company’s Chief Operating Officer since inception. Prior to Evox, he co-founded and served as CEO of IsletOne Therapeutics, a clinical stage cell therapy company. Previously, Dr Lundin managed a European business development segment for Thomson Reuters and prior to that qualified as a European Patent Attorney in the biotech practice of one of the largest European IP law firms. He started his career as a research scientist working on nanoparticle drug delivery. He earned his Ph.D. at the Karolinska Institute, holds an MSc in Biotechnology Engineering, and an MBA.